...
首页> 外文期刊>Social psychiatry and psychiatric epidemiology >The association between antidepressant use and deaths from road traffic accidents: a case-crossover study
【24h】

The association between antidepressant use and deaths from road traffic accidents: a case-crossover study

机译:来自道路交通事故的抗抑郁用途和死亡的关联:一个案例交叉研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PurposeAntidepressants are some of the most commonly used psychiatric medications, but little information is available about the effects of antidepressant treatment on the risk of traffic accidents across classes of antidepressants or associated with each substance individually. To investigate the relationship between exposure to antidepressants and risk of fatality in road traffic accidents.MethodsWe used a Korean national road traffic authority database linked with a national health insurance database between January 1, 2010 and December 31, 2014 and applied a case-crossover design. The study subjects were drivers in South Korea who died from traffic accidents and who had prescriptions for antidepressants within 1year prior to the date of the accident. We compared the status of prescription for antidepressants with the hazard period and four matched control periods using conditional logistic regression, adjusting for other drug use. The trends of antidepressant utilization were described in terms of the number of prescriptions. A case-case-time-control design was applied to drugs with an increasing trend in use and a significant case-crossover odds ratio (OR).ResultsA total of 1250 antidepressant-using drivers were included, and an increased risk was observed during the 30-day hazard period (adjusted OR 1.30; 95% CI 1.03-1.63). Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) showed significant risks, but tricyclic antidepressants did not. However, the associations of all antidepressants, SSRIs, SNRIs, escitalopram, and duloxetine did not remain significant after adjusting for trends in utilization. Paroxetine and milnacipran were associated with increased risks, with no obvious increase in their utilization, but the possibility of confounding by indication could have affected the results for milnacipran.ConclusionConsidering the trends of antidepressant prescription and utilization, the use of paroxetine increased the risk of fatal traffic accidents.
机译:purposeantpressper是一些最常用的精神病药物,但抗抑郁治疗对跨抗抑郁药类或单独相关的各种物质相关的抗抑郁药治疗的影响很少。探讨暴露于抗抑郁药与道路交通事故中致命风险之间的关系。近奇地区的韩国国家道路交通当局数据库与2010年1月1日至2014年12月31日之间的国家健康保险数据库联系在一起,并应用了案例交叉设计。研究科目是韩国的司机,他从交通事故中死亡,并且在事故日期之前患有1年内的抗抑郁药处方。将抗抑郁药处方的状态与危险期和四个匹配的控制期进行了比较,使用条件逻辑回归,调整其他药物使用。根据处方数量描述了抗抑郁用途的趋势。将案例计时设计应用于具有越来越多的使用趋势的药物,并且包括一个显着的壳体交叉量比(或)。患者总共1250个抗抑郁药司机,并且在此期间观察到的风险增加30天危险期(调整或1.30; 95%CI 1.03-1.63)。选择性血清素再摄取抑制剂(SSRIS)和血清素 - 去甲肾上腺素再摄取抑制剂(SNRIS)显示出显着的风险,但三环抗抑郁药没有。然而,所有抗抑郁药,SSRIS,SNRIS,ESCITALOPRAM和DULOXETINE的关联在调整利用趋势后,在调整趋势之后并未保持显着。帕罗西汀和米纳加西普兰与风险增加有关,其利用率没有明显增加,但暗示的可能性可能会影响MilnaCipran的结果。结论抗抑郁药剂处方和利用的趋势,帕罗西汀的使用增加了致命风险交通意外。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号